Replicor Compassionate Access Program

NCT05683548 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Viral Hepatitis B
Viral Hepatitis D
Cirrhosis, Liver
Decompensated Cirrhosis
Ascites Hepatic
Varices, Esophageal
Hepatocellular Carcinoma

Interventions

DRUG: REP 2139-Mg
DRUG: Tenofovir Disoproxil Fumarate
DRUG: Pegylated interferon alpha2a

Sponsor

Replicor Inc.